Clinical Trial Results: RMP-A03 Ocular Suspension in Patients With Pterygium [Phase 2]

View source ↗

Summary

Phase 2 clinical trial results for RMP-A03 ocular suspension in patients with pterygium have been completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pterygium

Drugs mentioned

• RMP-A03 ocular suspension (RMP-A03)

Snippet

Sponsor: Suzhou Raymon Pharmaceuticals Company, Ltd. | Conditions: Pterygium | Phase 2 | Status: COMPLETED | Results posted: 2026-06-05